These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 20497188)

  • 1. Construction of, and T-helper (Th)1/Th2 immune responses to, a herpes simplex virus type 2 glycoprotein D-cytotoxic T-lymphocyte epitope DNA vaccine.
    Huilan Y; Cui Z; Jianyong F; Lei G; Wei Q
    Clin Exp Dermatol; 2010 Jul; 35(5):537-42. PubMed ID: 20497188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective induction of type 1 cytotoxic T cell responses in mice with DNA vaccine encoding two hepatitis C virus cytotoxic T lymphocyte epitopes.
    Shi L; Liu S; Fan GX; Sheng L; Ren HX; Yuan YK
    Viral Immunol; 2006; 19(4):702-11. PubMed ID: 17201665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
    Fu TM; Bonneau RH; Epler M; Tevethia MJ; Alam S; Verner K; Tevethia SS
    Virology; 1996 Aug; 222(1):269-74. PubMed ID: 8806508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of N-glycosylation sites of hepatitis C virus envelope protein E1 enhances specific cellular and humoral immune responses.
    Liu M; Chen H; Luo F; Li P; Pan Q; Xia B; Qi Z; Ho WZ; Zhang XL
    Vaccine; 2007 Sep; 25(36):6572-80. PubMed ID: 17675185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting.
    Fotouhi F; Soleimanjahi H; Roostaee MH; Behzadian F
    FEMS Immunol Med Microbiol; 2008 Oct; 54(1):18-26. PubMed ID: 18647350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
    Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
    Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of humoral and cellular immune responses against HSV-1 using genetic immunization by filamentous phage particles: a comparative approach to conventional DNA vaccine.
    Hashemi H; Bamdad T; Jamali A; Pouyanfard S; Mohammadi MG
    J Virol Methods; 2010 Feb; 163(2):440-4. PubMed ID: 19903497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A kinetic study of gamma interferon production in herpes simplex virus-1 DNA prime-protein boost regimen comparing to DNA or subunit vaccination].
    Arefian E; Bamdad T; Soleimanjahi H; Akhood MR; Parsania M; Ghaemi A
    Mol Biol (Mosk); 2009; 43(3):422-8. PubMed ID: 19548528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D.
    Li WR; Niu B; Wang JW; Feng ZJ; Wang DX
    Acta Virol; 2006; 50(4):251-6. PubMed ID: 17177610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of apoptotic and anti-apoptotic genes on efficacy of DNA vaccine encoding glycoprotein B of Herpes Simplex Virus type 1.
    Parsania M; Bamdad T; Hassan ZM; Kheirandish M; Pouriayevali MH; Sari RD; Jamali A
    Immunol Lett; 2010 Feb; 128(2):137-42. PubMed ID: 20026118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full length antigen priming enhances the CTL epitope-based DNA vaccine efficacy.
    Pouriayevali MH; Bamdad T; Parsania M; Sari RD
    Cell Immunol; 2011; 268(1):4-8. PubMed ID: 21324438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
    Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M
    Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering of N-glycosylation of hepatitis C virus envelope protein E2 enhances T cell responses for DNA immunization.
    Li P; Wan Q; Feng Y; Liu M; Wu J; Chen X; Zhang XL
    Vaccine; 2007 Feb; 25(8):1544-51. PubMed ID: 17055129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intramuscular and footpad subcutaneous immunization with DNA vaccine encoding HSV-gD2 in mice.
    Jazayeri M; Soleimanjahi H; Fotouhi F; Pakravan N
    Comp Immunol Microbiol Infect Dis; 2009 Sep; 32(5):453-61. PubMed ID: 18571235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic influenza virosomes as an adjuvanted delivery system for CTL induction by DNA vaccination.
    Jamali A; Holtrop M; de Haan A; Hashemi H; Shenagari M; Memarnejadian A; Roohvand F; Sabahi F; Kheiri MT; Huckriede A
    Immunol Lett; 2012; 148(1):77-82. PubMed ID: 22981929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.
    Cui FD; Asada H; Kishida T; Itokawa Y; Nakaya T; Ueda Y; Yamagishi H; Gojo S; Kita M; Imanishi J; Mazda O
    Gene Ther; 2003 Dec; 10(25):2059-66. PubMed ID: 14595378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope mapping of full-length glycoprotein D from HSV-2 reveals a novel CD4+ CTL epitope located at the transmembrane-cytoplasmic junction.
    Cooper D; Mester JC; Guo M; Nasar F; Souza V; Dispoto S; Sidhu M; Hagen M; Eldridge JH; Natuk RJ; Pride MW
    Cell Immunol; 2006 Feb; 239(2):113-20. PubMed ID: 16762332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice.
    Barfoed AM; Rodriguez F; Therrien D; Borrego B; Sobrino F; Kamstrup S
    Antiviral Res; 2006 Dec; 72(3):178-89. PubMed ID: 16890298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.